Quantcast

Latest gout Stories

2010-11-08 06:00:00

SAN DIEGO, Nov. 8, 2010 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced positive results from two clinical studies of RDEA594 in combination with currently marketed drugs for the treatment of gout patients, febuxostat (Uloric®) and allopurinol. RDEA594, Ardea's lead product candidate for the chronic management of hyperuricemia and gout, is an orally administered compound that inhibits the URAT1 transporter, a biological mechanism that...

2010-11-05 07:00:00

CAMBRIDGE, Mass., Nov. 5, 2010 /PRNewswire/ -- Sermo (http://www.sermo.com), the world's largest online community for physicians, today announced a free Sermo Report titled, "Treatment Options for Gout". The report gathered feedback from physicians to better understand how they currently treat gout and if they would consider using new treatments. While many physicians who participated felt that current gout treatments effectively manage acute and suppressed gout flares, 63% confirmed...

2010-11-03 11:50:00

CHICAGO, Nov. 3, 2010 /PRNewswire/ --Don't let sore, achy feet ruin your holiday season. The American College of Foot and Ankle Surgeons offers five tips to healthy holiday feet. 1. If the shoe fits, wear it--When hitting the dance floor or the shopping malls during the holiday season, don't compromise comfort and safety when picking the right shoes to wear. Narrow shoes, overly-high-heeled ones or shoes that aren't worn very often, such as dress shoes, can irritate feet and lead to...

d3d447817df246504204ce301e7fe0061
2010-10-27 14:15:00

A new study has found that regular consumption of soda and other sugar-sweetened beverages is associated with a clear and consistently greater risk of metabolic syndrome and type 2 diabetes. According to the Harvard School of Public Health (HSPH) researchers, the study provides empirical evidence that intake of sugary beverages should be limited to reduce risk of these conditions. The study appears online October 27, 2010, in the journal Diabetes Care and will appear in the November print...

2010-10-14 07:00:00

EXTON, Pa., Oct. 14 /PRNewswire/ -- BioTrends Research Group, Inc. is pleased to announce the recent release of a syndicated report focused on the management and treatment of gout in the US. ChartTrends®: Gout is an annual publication based on patient and laboratory data collected from over 1,000 gout patient charts. It provides insight into the factors that drive decisions to treat, brand selection of uric acid lowering (UAL) therapies, patient characterizations and...

2010-09-30 13:48:00

Drug commonly used to prevent gout, treat gout flares, and treat Familial Mediterranean Fever (FMF) SILVER SPRING, Md., Sept. 30 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of Familial Mediterranean Fever (FMF). (Logo:...

2010-09-14 17:09:00

EAST BRUNSWICK, N.J., Sept. 14 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA(TM) (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and...

2010-09-14 16:52:00

SILVER SPRING, Md., Sept. 14 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Krystexxa (pegloticase) to treat the painful condition known as gout in adults who do not respond to or who cannot tolerate conventional therapy. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Gout occurs due to an excess of the bodily waste uric acid, which is eventually deposited as needle-like crystals...

2010-09-13 16:05:00

ATLANTA and DEERFIELD, Ill., Sept. 13 /PRNewswire/ -- The Arthritis Foundation and Takeda Pharmaceuticals North America, Inc., today announced the launch of a new educational campaign, Gout Living, to help increase understanding and encourage better management of gout. The campaign, which includes the first-ever gout public service announcements (PSAs), aims to encourage those living with the disease to be proactive about their health. The PSAs, which will be available via television, radio...

2010-08-06 07:30:00

SAN DIEGO, Aug. 6 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA), a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, today reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2010. "Since our last quarterly update, we have presented additional clinical results further supporting RDEA594's efficacy and favorable tolerability when administered as a...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related